Physician profile
Thomas A Parfenchuck
NPI 1053346973
$792.96
in general payments reported to CMS, 2019-2025
14 companies · $340 in 2025
The $340 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.29 · 2020: $22.62 · 2021: $101 · 2022: $34.30 · 2023: $137 · 2024: $133 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intrinsic Therapeutics | $177.42 | 2025 | Barricaid Acd (Annular Closure Device) |
| Fidia Pharma USA INC. | $115.23 | 2023 | Triluron, Hymovis |
| Providence Medical Technology, INC. | $76.51 | 2024 | |
| Boston Scientific Corporation | $67.70 | 2019-2024 | |
| Stryker Corporation | $66.64 | 2021 | |
| Orthofix Medical, INC. | $55.90 | 2025 | Firebird Si Navigation System |
| Innovation Technologies INC | $50.22 | 2025 | Irrisept |
| Horizon Therapeutics Plc | $50.00 | 2021-2022 | |
| Bioventus LLC | $40.10 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Spineology INC. | $22.62 | 2020 | |
| Baxter Healthcare | $21.94 | 2023 | Floseal |
| Amgen INC. | $18.28 | 2024 | Krystexxa |
| Si-Bone, INC. | $16.01 | 2025 | |
| Orthogenrx INC. | $14.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Parfenchuck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.